GILD vs SEVN · P/E 18, rev $7.80B vs P/E 9.5, rev $29.4M
Gilead Sciences Inc (GILD) versus Seven Hills Realty Trust (SEVN) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Seven Hills Realty Trust (SEVN) is a reit - mortgage company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported SEVN revenue for 2025-12-31 was $29.4M. Net income was $15.4M. Revenue was down 16.7% from 2024-12-31 to 2025-12-31. SEVN currently screens at market cap $193.0M and trailing P/E 9.5.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. SEVN currently screens at market cap $193.0M and trailing P/E 9.5.
Not investment advice. Open the GILD and SEVN stock pages for the full models.
Not investment advice.